Metagenomi revenue was $52.30M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $9.6M, down 16.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MGX annual revenue was $52.3M, with 16.8% growth year-over-year.
MGX past revenue growth
How has MGX's revenue growth performed historically?
Metagenomi (NASDAQ: MGX) reported Q4 2024 revenue of $9.61 million up 22.46% year over year. In the same quarter last year, Metagenomi's revenue was $12.40 million.
What was Metagenomi's revenue in 2024?
Metagenomi's annual revenue for the twelve months ending Dec 31, 2024 was $52.30 million, a 16.84% increase year over year.
How much does Metagenomi make in a day?
Based on Metagenomi annual revenue for the past three years, MGX makes an average of $104,338.81 per day.
What was Metagenomi's annual revenue growth in the past year?
As of Q2 2025, Metagenomi's revenue has grown 16.84% year over year. This is 420.46 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Metagenomi's revenue in the past year totaled $52.30 million.
How much does Metagenomi make in a year?
Metagenomi's revenue by year for the past three years is:
Metagenomi's revenue for the twelve months ending Dec 31, 2024 was $52.30 million, a 16.84% increase year over year.
Metagenomi's annual revenue for Dec 31, 2023 was $44.76 million, a 160.21% increase from 2022.
Metagenomi's annual revenue for 2022 was $17.20 million, a 6,978.19% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.